The cochlear implants market valued at US$ 2.58 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ ...
RedHill Biopharma Ltd (RDHL) reported its Q1 2022 earnings, revealing a decrease in net revenues to $18.2 million from $22.1 million in the previous quarter. Despite this, the company achieved a gross ...
The cochlear implants market valued at US$ 2.58 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 2.80 Billion in ...